Can We Do Better with a New Chemotherapy for Squamous Cell NSCLC? episode artwork

EPISODE · Jul 9, 2015 · 2 MIN

Can We Do Better with a New Chemotherapy for Squamous Cell NSCLC?

from GRACEcast · host cancerGRACE Meetings

A Japanese study of squamous cell carcinoma showed value in nedaplatin vs cisplatin/Taxotere (docetaxel). But with differences in how Asian versus Caucasian patients metabolize chemotherapy, can we presume this benefit would exist for everyone?

Episode metadata supplied by the publisher feed · Published Jul 9, 2015

Embed this episode

NOW PLAYING

Can We Do Better with a New Chemotherapy for Squamous Cell NSCLC?

0:00 2:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 2 minutes long.

When was this GRACEcast episode published?

This episode was published on July 9, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!